in women with positive aPL because estrogen increases risk of thromboembolism. We strongly recommend IUDs (levonorgestrel or copper) or the progestin-only pill in women with positive aPL. In aPL-positive patients, we do not recommend DMPA due to concern regarding thrombogenicity. We do not comment on the relatively new progestin implant due to lack of data. The risk of venous thromboembolism (VTE) in healthy women taking combined estrogen-progestin contraceptives is 36 times higher than the